Address: (Linghao Road) No.2 Street, No.20 Economic Development Zone, Hangzhou
HP High Pressure PTCA Balloon Catheter Applicable to patients with coronary artery stenosis or patients with occlusive lesions were performed percutaneous cavity coronary angioplasty. Non Compliance & High Burst Pressure Ideal for Post-dilatation after DES implantation Extremely low balloon......Send Inquiry
HP High Pressure PTCA Balloon Catheter
Applicable to patients with coronary artery stenosis or patients with occlusive lesions were performed percutaneous cavity coronary angioplasty.
Non Compliance & High Burst Pressure
Ideal for Post-dilatation after DES implantation
Extremely low balloon compliance designed for post-dilatation after DES
Strengthened balloon material selected for high pressure challenge during PCI
Low profile dilatation catheter for optimal tracking and crossing
Rated Burst Pressure
Average Burst Pressure
Profile (3.0mm standard)
Lesion Entry Profile
With a tapered smooth tip,
Reduce damage to the vessel wall.
Independent research and development of hydrophilic coating process, ultra-sliding push.
-Kissing balloon technique
Can be used for kiss balloon technology.
-Three layer inner tube
Selection of three layer inner tube (Nylon12 / Orevac / HDPE), maintain the low hardness and guide wire patency.
-Fast exchange conveyer system
Easy to control, reduce the operation time, reduce the risk of surgery 30cm fast exchange section
Compatible with 0.014 inch microcircuit
Since its foundation in 2015, Barty has made many achievements, including about 20 core patents, CE certificate of 5 produces. Fore more, paclitaxel eluting PTCA balloon expansion catheter became the first to get "green channel" approved by SFDA in China. Paclitaxel-eluting peripheral stent system was selected as "2017 Zhejiang Key R&D project." Barth Medical has already possessed the core competitive products and cutting-edge technologies.